The Kara Gelb Memorial Grant is awarded in memory of an original member of the ACCRF Board of Directors and is bestowed upon a promising early- or mid-career investigator who is focusing on translating basic research into improved therapies for ACC patients. You can read more about Kara here.
Renata Ferrarotto, MD
MD Anderson Cancer Center
“Multicenter Validation of P63 Immunohistochemistry (IHC) as a Prognostic Marker for Adenoid Cystic Carcinoma.”
Maxim Pimkin, MD, PhD
Dana-Farber Cancer Institute
“Targeted protein degradation approaches to define the molecular mechanisms of MYB oncoproteins in ACC”
Dr. Alexander Pearson, MD, PhD
University of Chicago Medicine
“Deep Neural Network Development for Adenoid Cystic Carcinomas”
Piero Dalerba, MD
Columbia University
“Pharmacological manipulation of cell differentiation in human Adenoid Cystic Carcinomas (ACCs).”